marijuana stocks news

Form 8-K for CHUMA HOLDINGS, INC.

13-Jan-2015

Other Events

Item 8.01 Other Events.Effective January 9, 2015, the British Columbia Securities Commission (the “BCSC”), the market regulatory authority in the province of British Columbia, Canada, issued a temporary halt trade order on Chuma Holdings, Inc.’s (the “Company”) common stock which halted trading in the stock in the province of British Columbia until the end of business on January 29, 2015. The Company is informed and believes that this temporary halt trade order is directly related to unauthorized third party investor relations promotional campaigns discovered by the Company and disclosed via Company press release on January 9, 2015.

The Company further believes that the offending promotional campaigns have since been taken down. The Company will continue to work closely with the BCSC to ensure that citizens of British Columbia will be able to resume trading in the Company’s common stock as soon as possible. The Company again would like to reiterate that it focuses upon ensuring that all public communications are accurate and in compliance with applicable securities laws and cautions investors about relying on unauthorized promotional campaigns.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
1 comment
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

PotNetwork Holding, Inc. (POTN) Diamond CBD Takes in over $300,000 in Sales at CHAMPS Summer Show

PotNetwork Holding, Inc. Wholly Owned Subsidiary Diamond CBD Takes in over $300,000…

Grow Capital, Inc (GRWC) Signs Exchange Agreement To Acquire Bombshell Technologies

Grow Capital, Inc Signs Exchange Agreement To Acquire Bombshell Technologies Grow Capital,…

Greenlane Holdings, Inc. (GNLN) And KushCo Holdings Inc. (KSHB) Announce Transformative Merger, Creating the Leading Ancillary Cannabis Company

Greenlane and KushCo Announce Transformative Merger, Creating the Leading Ancillary Cannabis Company…

Cara Therapeutics, Inc. (CARA) Announces Initiation of Phase 2 Trial of Oral KORSUVA™

Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin)…